Glenn J. Hanna, MD

Dr. Hanna completed his fellowship training in hematology and medical oncology at Dana-Farber Cancer Institute in 2016. Prior to this, he earned his medical degree from Georgetown University School of Medicine in 2010, where he graduated summa cum laude, a member of Alpha Omega Alpha Honor Society and the Kober Medalist for academic excellence. He joined the faculty of the Center for Head and Neck Oncology in 2017. Dr. Hanna is the Director of the Center for Cancer Therapeutic Innovation (CCTI), the early drug development program at DFCI.  His clinical and translational research efforts focus on precision medicine approaches to treat head and neck cancers.  He has special interests in salivary gland cancers and rare head and neck malignancies, and in molecular and immunologic biomarker discovery.